rubitecan has been researched along with HIV Coinfection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doniger, J; Mayner, R; Sadaie, MR | 1 |
| Epstein, JS; Moulton, S; Pantazis, P; Sadaie, MR | 1 |
| Doniger, J; Hung, CL; Pantazis, P; Sadaie, MR | 1 |
| Brady, JN; Doniger, J; Hung, CL; Palini, A; Pantazis, P; Radonovich, MF; Sadaie, MR; Snyder, SW | 1 |
1 review(s) available for rubitecan and HIV Coinfection
| Article | Year |
|---|---|
A novel approach to develop anti-HIV drugs: adapting non-nucleoside anticancer chemotherapeutics.
Topics: Anti-HIV Agents; Antimetabolites; Antineoplastic Agents; Apoptosis; Camptothecin; Cyclin-Dependent Kinases; Flavonoids; HIV; HIV Infections; Humans; Piperidines; Purines; Receptors, Estrogen; Roscovitine; Topoisomerase I Inhibitors; Virus Replication | 2004 |
3 other study(ies) available for rubitecan and HIV Coinfection
| Article | Year |
|---|---|
9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle; HIV Infections; HIV-1; Humans; RNA, Messenger; RNA, Viral; T-Lymphocytes; Tumor Necrosis Factor-alpha; Up-Regulation; Virus Activation | 1998 |
9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells.
Topics: Anti-HIV Agents; Antineoplastic Agents; Camptothecin; Drug Resistance; HIV Infections; HIV-1; Humans; NF-kappa B; Tumor Cells, Cultured; U937 Cells; Virus Replication | 1999 |
9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Apoptosis; Camptothecin; Cell Cycle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Flow Cytometry; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kinetics; Lymphocytes; Reverse Transcriptase Inhibitors; Virus Replication | 2001 |